Are the vascular complications of diabetes mellitus preceded by an altered thromboxane/prostacyclin plasmatic ratio?
- 1 March 1986
- journal article
- research article
- Published by Elsevier in Medical Hypotheses
- Vol. 19 (3), 229-241
- https://doi.org/10.1016/0306-9877(86)90070-8
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Circulating immune complexes and platelet thromboxane synthesis in patients with insulin-dependent (type I) diabetes mellitusDiabetes, 1984
- IgA- and insulin-containing (C3-fixing) circulating immune complexes in diabetes mellitusClinical Immunology and Immunopathology, 1984
- Simian Sarcoma Virus onc Gene, v- sis , Is Derived from the Gene (or Genes) Encoding a Platelet-Derived Growth FactorScience, 1983
- Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virusNature, 1983
- Platelets from diabetic subjects show diminished sensitivity to prostacyclinEuropean Journal of Clinical Investigation, 1982
- An Inverse Correlation between Plasma Prostacyclin and Serum TriglyceridesNew England Journal of Medicine, 1980
- Effect of Cholesterol on Production of Thromboxane B2by Platelets in VitroNew England Journal of Medicine, 1980
- Decreased Vascular Prostacyclin in Juvenile-Onset DiabetesNew England Journal of Medicine, 1979
- Biosynthesis of prostacyclin in rat liver endothelial cells and its control by prostaglandin E2Nature, 1978
- The effects of immune complexes on blood platelets and their relationship to complement activationImmunochemistry, 1972